Indonesian Health Issue
Vol. 5 No. 1 (2026): FEBRUARY

TAK-003 Dengue Vaccine Efficacy and Safety: A Systematic Literature Review Using PRISMA

Galih Muchlis Hermawan (Unknown)
Syuharul Qomar (Unknown)
Iga Putri Imansari (Unknown)



Article Info

Publish Date
03 Feb 2026

Abstract

Background: Dengue is a global public health problem with a high disease burden in both endemic and non-endemic regions. Although dengue vaccines have been developed, evidence regarding the efficacy and safety of the TAK-003 vaccine remains fragmented, with variations across serotypes, age groups, baseline serostatus, and study designs. Objective: This study aims to analyze and synthesize scientific evidence on the efficacy and safety of the tetravalent dengue vaccine TAK-003 based on clinical trial data and real-world evidence. Methods: A Systematic Literature Review was conducted in January 2025 in accordance with PRISMA guidelines. Literature searches were performed in the ScienceDirect, PubMed, ProQuest, and ClinicalKey databases, yielding a total of 1,011 initial records. After duplicate removal, title and abstract screening, and full-text eligibility assessment, studies were included if they: (1) explicitly investigated TAK-003, (2) reported outcomes related to efficacy, immunogenicity, and/or safety, (3) employed clinical trial, observational, or post-marketing surveillance designs, and (4) were available as full-text articles in English. Non-empirical studies, animal studies, commentaries, and narrative reviews were excluded. Results: Five high-quality articles from Scopus Q1 journals met the inclusion criteria. The thematic analysis identified five main themes: the safety and immunogenicity of TAK-003 when co-administered with other vaccines, manufacturing consistency with stable immune responses, long-term effectiveness in preventing dengue infection and hospitalization for up to 4.5 years, tetravalent protection against all four dengue serotypes, and a favorable safety profile based on post-marketing data, with most adverse events being mild. Conclusion: The TAK-003 vaccine demonstrates favorable efficacy and safety profiles in both clinical trials and real-world settings. Although variability in effectiveness across serotypes and age groups persists, the available evidence supports TAK-003 as a promising strategy for dengue prevention.

Copyrights © 2026






Journal Info

Abbrev

inhis

Publisher

Subject

Dentistry Health Professions Medicine & Pharmacology Nursing Public Health Veterinary

Description

Indonesian Health Journal is one of the journals which is concerned with the health field. It was published in 2022 by PublishingId. Indonesian Health Journal adopts a double-blind peer review policy and concerns on various health fields, for instance NURSING, MIDWIFERY, NUTRITION, MEDICAL LAB ...